These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 17911267)

  • 1. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance.
    Zhou J; Wulfkuhle J; Zhang H; Gu P; Yang Y; Deng J; Margolick JB; Liotta LA; Petricoin E; Zhang Y
    Proc Natl Acad Sci U S A; 2007 Oct; 104(41):16158-63. PubMed ID: 17911267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells.
    Marty B; Maire V; Gravier E; Rigaill G; Vincent-Salomon A; Kappler M; Lebigot I; Djelti F; Tourdès A; Gestraud P; Hupé P; Barillot E; Cruzalegui F; Tucker GC; Stern MH; Thiery JP; Hickman JA; Dubois T
    Breast Cancer Res; 2008; 10(6):R101. PubMed ID: 19055754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway is critical for survival and proliferation of pancreatic cancer stem-like side population cells].
    Zhou J; Wang CY; Liu T; Wu HS; Zhou F; Xiong JX; Zhao G; Yang M; Yin T; Zhou MT
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(42):2994-8. PubMed ID: 19080079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells.
    Jung MJ; Rho JK; Kim YM; Jung JE; Jin YB; Ko YG; Lee JS; Lee SJ; Lee JC; Park MJ
    Oncogene; 2013 Jan; 32(2):209-21. PubMed ID: 22370645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HINT3 suppresses AKT/mTOR signaling pathway activity during breast cancer tumorigenesis through PTEN transcriptional activation.
    Li J; Liu Y; Lian B; Li H; Chai D; Gao Y; Wang Y
    Int J Mol Med; 2023 Jul; 52(1):. PubMed ID: 37203409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of phosphatase and tensin homolog (PTEN) induces leptin-mediated leptin gene expression: feed-forward loop operating in the lung.
    Pathak RR; Grover A; Malaney P; Quarni W; Pandit A; Allen-Gipson D; Davé V
    J Biol Chem; 2013 Oct; 288(41):29821-35. PubMed ID: 23963458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression.
    Mao JH; Kim IJ; Wu D; Climent J; Kang HC; DelRosario R; Balmain A
    Science; 2008 Sep; 321(5895):1499-502. PubMed ID: 18787170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PTEN/PI3K/Akt pathway regulates stem-like cells in primary esophageal carcinoma cells.
    Li H; Gao Q; Guo L; Lu SH
    Cancer Biol Ther; 2011 Jun; 11(11):950-8. PubMed ID: 21467840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The VHL tumor suppressor protein regulates tumorigenicity of U87-derived glioma stem-like cells by inhibiting the JAK/STAT signaling pathway.
    Kanno H; Sato H; Yokoyama TA; Yoshizumi T; Yamada S
    Int J Oncol; 2013 Mar; 42(3):881-6. PubMed ID: 23338840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
    Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
    EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer.
    Milella M; Falcone I; Conciatori F; Matteoni S; Sacconi A; De Luca T; Bazzichetto C; Corbo V; Simbolo M; Sperduti I; Benfante A; Del Curatolo A; Cesta Incani U; Malusa F; Eramo A; Sette G; Scarpa A; Konopleva M; Andreeff M; McCubrey JA; Blandino G; Todaro M; Stassi G; De Maria R; Cognetti F; Del Bufalo D; Ciuffreda L
    Sci Rep; 2017 Feb; 7():43013. PubMed ID: 28220839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side population in MDA-MB-231 human breast cancer cells exhibits cancer stem cell-like properties without higher bone-metastatic potential.
    Hiraga T; Ito S; Nakamura H
    Oncol Rep; 2011 Jan; 25(1):289-96. PubMed ID: 21109989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations.
    Dubrovska A; Kim S; Salamone RJ; Walker JR; Maira SM; García-Echeverría C; Schultz PG; Reddy VA
    Proc Natl Acad Sci U S A; 2009 Jan; 106(1):268-73. PubMed ID: 19116269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.
    Wei W; Tweardy DJ; Zhang M; Zhang X; Landua J; Petrovic I; Bu W; Roarty K; Hilsenbeck SG; Rosen JM; Lewis MT
    Stem Cells; 2014 Oct; 32(10):2571-82. PubMed ID: 24891218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer.
    Zhang ZH; Li MY; Wang Z; Zuo HX; Wang JY; Xing Y; Jin C; Xu G; Piao L; Piao H; Ma J; Jin X
    Phytomedicine; 2020 Mar; 68():153172. PubMed ID: 32004989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K/Akt and Stat3 signaling regulated by PTEN control of the cancer stem cell population, proliferation and senescence in a glioblastoma cell line.
    Moon SH; Kim DK; Cha Y; Jeon I; Song J; Park KS
    Int J Oncol; 2013 Mar; 42(3):921-8. PubMed ID: 23314408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway.
    Xu DD; Zhou PJ; Wang Y; Zhang L; Fu WY; Ruan BB; Xu HP; Hu CZ; Tian L; Qin JH; Wang S; Wang X; Li YC; Liu QY; Ren Z; Zhang R; Wang YF
    Mol Cancer; 2016 May; 15(1):40. PubMed ID: 27189061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STX3 represses the stability of the tumor suppressor PTEN to activate the PI3K-Akt-mTOR signaling and promotes the growth of breast cancer cells.
    Nan H; Han L; Ma J; Yang C; Su R; He J
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1684-1692. PubMed ID: 29408595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells.
    Zhou J; Zhang H; Gu P; Bai J; Margolick JB; Zhang Y
    Breast Cancer Res Treat; 2008 Oct; 111(3):419-27. PubMed ID: 17965935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.